Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia.

Deak D, Pop C, Zimta AA, Jurj A, Ghiaur A, Pasca S, Teodorescu P, Dascalescu A, Antohe I, Ionescu B, Constantinescu C, Onaciu A, Munteanu R, Berindan-Neagoe I, Petrushev B, Turcas C, Iluta S, Selicean C, Zdrenghea M, Tanase A, Danaila C, Colita A, Colita A, Dima D, Coriu D, Einsele H, Tomuleasa C.

Front Immunol. 2019 Dec 20;10:2856. doi: 10.3389/fimmu.2019.02856. eCollection 2019.

2.

Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.

Onisâi M, Vlădăreanu AM, Nica A, Spînu A, Găman M, Bumbea H, Voican I, Iordan I, Alexandru A, Zdrenghea M, Gheorghita D, Grădinaru S.

Medicina (Kaunas). 2019 Dec 27;56(1). pii: E12. doi: 10.3390/medicina56010012.

3.

Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients?

Popescu CM, Ursache AL, Feketea G, Bocsan C, Jimbu L, Mesaros O, Edwards M, Wang H, Berceanu I, Neaga A, Zdrenghea M.

Microorganisms. 2019 Nov 2;7(11). pii: E521. doi: 10.3390/microorganisms7110521. Review.

4.

Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology.

Moisoiu V, Teodorescu P, Parajdi L, Pasca S, Zdrenghea M, Dima D, Precup R, Tomuleasa C, Soverini S.

Front Oncol. 2019 Sep 23;9:863. doi: 10.3389/fonc.2019.00863. eCollection 2019.

5.

Persistent Basophilia May Suggest an "Accelerated Phase" in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia.

Dobrowolski J, Pasca S, Teodorescu P, Selicean C, Rus I, Zdrenghea M, Bojan A, Trifa A, Fetica B, Petrushev B, Rosu AM, Berindan-Neagoe I, Tomuleasa C, Dima D.

Front Oncol. 2019 Sep 6;9:872. doi: 10.3389/fonc.2019.00872. eCollection 2019.

6.

CV RISK - A new relative cardiovascular risk score.

Zdrenghea D, Guşetu G, Zdrenghea M, Cismaru G, Caloian B, Vaidean G, Pop D.

Med Hypotheses. 2019 Nov;132:109362. doi: 10.1016/j.mehy.2019.109362. Epub 2019 Aug 12.

7.

Approach to the Adult Acute Lymphoblastic Leukemia Patient.

Sas V, Moisoiu V, Teodorescu P, Tranca S, Pop L, Iluta S, Pasca S, Blag C, Man S, Roman A, Constantinescu C, Rus I, Buse M, Fetica B, Marian M, Selicean C, Berindan-Neagoe I, Petrushev B, Bumbea H, Tanase A, Zdrenghea M, Fuji S, Kitano S, Tomuleasa C; Romanian-Japanese Working Group of the Romanian Society for Bone Marrow Transplantation.

J Clin Med. 2019 Aug 6;8(8). pii: E1175. doi: 10.3390/jcm8081175.

8.

A Review of Macrophage MicroRNAs' Role in Human Asthma.

Feketea G, Bocsan CI, Popescu C, Gaman M, Stanciu LA, Zdrenghea MT.

Cells. 2019 May 8;8(5). pii: E420. doi: 10.3390/cells8050420. Review.

9.

Transient leukemia of Down syndrome.

Sas V, Blag C, Zaharie G, Puscas E, Lisencu C, Andronic-Gorcea N, Pasca S, Petrushev B, Chis I, Marian M, Dima D, Teodorescu P, Iluta S, Zdrenghea M, Berindan-Neagoe I, Popa G, Man S, Colita A, Stefan C, Kojima S, Tomuleasa C.

Crit Rev Clin Lab Sci. 2019 Jun;56(4):247-259. doi: 10.1080/10408363.2019.1613629. Epub 2019 Jun 21.

PMID:
31043105
10.

Rapid and complete response to idelalisib in a case of Richter syndrome.

Bagacean C, Zdrenghea M, Saad H, Berthou C, Renaudineau Y, Tempescul A.

Onco Targets Ther. 2019 Feb 13;12:1181-1184. doi: 10.2147/OTT.S187459. eCollection 2019.

11.

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia.

Bagacean C, Tempescul A, Ternant D, Banet A, Douet-Guilbert N, Bordron A, Bendaoud B, Saad H, Zdrenghea M, Berthou C, Paintaud G, Renaudineau Y.

J Immunother Cancer. 2019 Jan 29;7(1):22. doi: 10.1186/s40425-019-0509-0.

12.

Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia.

Trifa AP, Bănescu C, Voina CM, Popa Ș, Török-Vistai T, Bojan AS, Dima D, Zdrenghea M, Fetica B, Vișan S, Tomuleasa C, Pârvu A, Urian L, Pop B, Popov VM, Andreescu M, Popp RA.

Blood Cells Mol Dis. 2018 Nov;73:45-46. doi: 10.1016/j.bcmd.2018.09.003. Epub 2018 Sep 20. No abstract available.

PMID:
30249383
13.

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.

Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I.

Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Review.

PMID:
30238808
14.

Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches.

Tomuleasa C, Selicean C, Cismas S, Jurj A, Marian M, Dima D, Pasca S, Petrushev B, Moisoiu V, Micu WT, Vischer A, Arifeen K, Selicean S, Zdrenghea M, Bumbea H, Tanase A, Grewal R, Pop L, Aanei C, Berindan-Neagoe I.

Crit Rev Clin Lab Sci. 2018 Aug;55(5):329-345. doi: 10.1080/10408363.2018.1463508. Epub 2018 May 25. Review.

PMID:
29801428
15.

DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag.

Bagacean C, Zdrenghea M, Dantec CL, Tempescul A, Berthou C, Renaudineau Y.

Future Sci OA. 2017 Nov 3;4(2):FSO265. doi: 10.4155/fsoa-2017-0120. eCollection 2018 Feb. No abstract available.

16.

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.

Bagacean C, Le Dantec C, Berthou C, Tempescul A, Saad H, Bordron A, Zdrenghea M, Cristea V, Douet-Guilbert N, Renaudineau Y.

Clin Epigenetics. 2017 Nov 28;9:122. doi: 10.1186/s13148-017-0422-7. eCollection 2017.

17.

Echocardiography as the first diagnostic clue to rapidly progressive systemic AL amyloidosis associated with multiple site thrombosis. A case report.

Caloian B, Zdrenghea D, Man SC, Costea S, Zdrenghea M, Pop D.

Med Ultrason. 2017 Nov 29;19(4):451-453. doi: 10.11152/mu-1095.

18.

Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR-ABL transcripts.

Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C.

Onco Targets Ther. 2017 Oct 19;10:5047-5051. doi: 10.2147/OTT.S146973. eCollection 2017.

19.

Advances in the treatment of newly diagnosed primary central nervous system lymphomas.

Qian L, Tomuleasa C, Florian IA, Shen J, Florian IS, Zdrenghea M, Dima D.

Blood Res. 2017 Sep;52(3):159-166. doi: 10.5045/br.2017.52.3.159. Epub 2017 Sep 25. Review.

20.

Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia.

Bagacean C, Tempescul A, Le Dantec C, Bordron A, Mohr A, Saad H, Olivier V, Zdrenghea M, Cristea V, Cartron PF, Douet-Guilbert N, Berthou C, Renaudineau Y.

Oncotarget. 2017 Aug 9;8(39):65699-65716. doi: 10.18632/oncotarget.20081. eCollection 2017 Sep 12.

Supplemental Content

Loading ...
Support Center